Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease-Reference-Cited by-同舟云学术

Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease

Published:2019-01-20 Issue:21 Volume: Page:16-21
ISSN:2658-5790
Container-title:Medical Council
language:
Short-container-title:Med. sov.

Author:

Sumarokov A. B.¹,Buryachkovskaya L. I.¹,Lomakin N. V.²

Affiliation:

1. Federal State Budgetary Institution «National Medical Research Center of Cardiology» of the Ministry of Health of the Russian Federation

2. Federal State Budgetary Institution «Central Clinical Hospital and Polyclinic» of Presidential Administration of the Russian Federation

Abstract

Thrombocytopenia in blood count may be a reflex of haemostatic problems of different origin – from autoimmune disease to iatrogenic nature. Sometimes, thrombocytopenia may be revealed in patient with coronary heart disease before PCI procedure as well as some hours or days later. Dual antithrombotic therapy and thrombocytopenia have the same main side effect – bleeding. Etiology of disease and details of medical decision before percutаneous coronary intervention (PCI) in CHD patients are discussed.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference22 articles.

1. Yadav M., Genereux P., Giustino G., Madhavan M.V., Brener S.J., Mintz G., Caixeta A., Xu K., Mehran R., Stone G.W. Effect of baseline thrombocytopenia on ischemic outcomes in patients with аcute coronary syndromes who undergo percutaneous coronary intervention. Canadian J Cardiology. 2016; 32: 226-233.

2. Vora A.N., Chenier M., Schulte P.J., Goodman S., Peterson E.D., Pieper K., Joulicoeur M.E., Mahaffey K.W., White H., Wang T.Y. Long-tern outcomes associated with hospital acquired thrombocytopenia among patients with nonST-segment elevation acute coronary syndrome. Am Heart J. 2014; 168(2): 189-196.

3. Wang T., Ou F-S., Roe M., Harrington R., Ohman E., Gibler W., Peterson E. Incidence and prognostic significance of thrombocytopenia developed during Acute Coronary Syndrome in contemporary clinical practice. Circulation. 2009; 119(18): 2454-2462.

4. Hakim D., Dangas G., Caixeta A., Nikolsky E., Lancky A., Moses J., Claesen B., Sanidas E., White H., Ohman E., Manoukian S., Fahy M., Mehrah R., Stone G. Impact of baseline thrombocytopenia on early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONZ-AMI) trial. Am Heart J. 2011; 161(2): 391-396.

5. Raphael C., Spoon D., Bell M., Psaltis P., Kidd S., Loh S., Lennon R., Singh M., Rihal C., Gulati R. Effect of preprocedural thrombocytopenia on prognosis after percutaneous coronary intervention. Mayo Clinic Proceedings. 2016; 91(8): 1035-1044.